LUS在儿童重症肺炎纤维支气管镜肺泡灌洗治疗前后的应用价值OA
LUS in Assessing Pre-and Post-treatment Outcomes of Fiberoptic Broncho-scopic Alveolar Lavage(BAL)for Pediatric Severe Pneumonia
目的:探讨肺脏超声(LUS)在儿童重症肺炎(SP)纤维支气管镜肺泡灌洗(BAL)治疗前后的应用价值,以评估其能否作为监测病情变化及疗效的有效手段.方法:选取2022年1月至2024年12月期间本院收治的200例SP患儿,本研究采用"单盲法",随机数字表法分为对照组(行常规抗感染治疗,n=100)和实验组(行纤维BAL治疗,n=100).治疗前后行LUS检查.观察并记录两组临床症状改善情况、肺功能指标[呼气峰值流量(PEF)、第一秒用力呼气容积(FEV1)、用力肺活量(FVC)]、肺实变范围、LUS评分(12个区域总分,共36分,分数越高代表病变越严重)、炎性因子[白细胞计数(WBC)、C反应蛋白(CRP)、降钙素原(PCT)]及LUS评分与炎性指标的相关性.结果:与对照组相比,实验组在纤维BAL治疗后,体温恢复时间[(9.67±1.65)h vs.(12.17±2.04)h]、咳嗽消失时间[(11.21±1.90)d vs.(14.26±2.27)d]、啰音消失时间[(10.89±1.73)d vs.(13.17±2.21)d]和住院时间[(12.97±3.49)d vs.(18.24±5.12)d]显著缩短(P<0.05);实验组PEF[(2.61±0.58)L vs.(2.02±0.59)L]、FEV1[(64.08±2.77)%vs.(59.82±2.41)%]、FVC[(1.86±0.42)L vs.(1.72±0.44)L]高于对照组(P<0.05);LUS显示实验组肺实变范围明显小于对照组[(10.43±3.06)cm2 vs.(15.29±4.69)cm2],LUS评分也明显降低[(6.81±2.03)分vs.(8.11±2.18)分](P<0.05);另外实验组炎性因子WBC[(8.28±1.16)×109/L vs.(10.76±1.38)×109/L]、CRP[(14.01±1.89)U/L vs.(20.73±2.56)U/L]、PCT[(0.60±0.08)μg/L vs.(0.91±0.10)μg/L]水平低于对照组(P<0.05),LUS评分与炎性因子WBC、CRP、PCT呈正相关(对照组:r=0.261、0.333、0.388,均P<0.001;实验组:r=0.341、0.474、0.472,均P<0.001).结论:LUS可量化评估儿童SP肺部病变情况,其评分与炎症程度高度相关,能有效监测纤维BAL治疗的效果,为床旁无辐射动态评估提供可靠依据.
Objective:To explore the significance of lung ultrasound(LUS)assessments conducted both prior to and following fibreoptic bronchoscopic alveolar lavage(BAL)therapy in pediatric patients with severe pneumonia(SP),in order to assess whether it can be used as an effective means of monitoring the changes in the condition and the efficacy of treatment.Methods:Between January 2022 and December 2024,200 pediatric patients with SP at our hospital were recruited,the patients were divided into a control group(routine anti-infective treatment,n=100)and an experimental group(fiberoptic BAL treatment,n=100)using a single-blind method and a random number table.Both groups underwent LUS examinations pre-and post-treatment.Clinical symptom improvement,pulmonary function parameters[peak expiratory flow(PEF),forced expiratory volume in one second(FEV1),forced lung capacity(FVC)],extent of solid lung lesions,LUS score(total score for 12 regions out of 36,with higher scores representing more severe lesions),inflammatory markers[white blood cell counts(WBCs),C-reactive protein(CRPs),procalcitonin(PCT)],and correlations between LUS scores and inflammatory markers were recorded and analyzed.Results:In comparison to the control group,the experimental group exhibited a significant reduction in the time to recovery of body temperature[(9.67±1.65)h vs.(12.17±2.04)h],the time to disappearance of cough[(11.21±1.90)d vs.(14.26±2.27)d],the time to disappearance of rales[(10.89±1.73)d vs.(13.17±2.21)d]and the hospitalisation time[(12.97±3.49)d vs.(18.24±5.12)d]after BAL treatment(P<0.05),and the increase in PEF[(2.61±0.58)L vs.(2.02±0.59)L],FEV1[(64.08±2.77)%vs.(59.82±2.41)%],andFVC[(1.86±0.42)L vs.(1.72±0.44)L]was more pronounced in the experimental group(P<0.05).The LUS showed that the experimental group had a notably smaller area of solid pulmonary lesions compared to the control group[(10.43±3.06)cm2 vs.(15.29±4.69)cm2],accompanied by a significantly lower LUS score[(6.81±2.03)points vs.(8.11±2.18)points](P<0.05).In addition,the experimental group exhibited a more pronounced decrease in inflammatory markers,including WBC[(8.28±1.16)×109/L vs.(10.76±1.38)×109/L],CRP[(14.01±1.89)U/L vs.(20.73±2.56)U/L],PCT[(0.60±0.08)μg/L vs.(0.91±0.10)μg/L]levels(P<0.05).Additionally,there was a positive correlation between the LUS score and WBC、CRP、PCT(the control group:r=0.261,0.333,0.388,P<0.001;the experimental group:r=0.341,0.474,0.472,P<0.001).Conclusion:LUS quantitatively assesses SP lung lesions in children,and its score is highly correlated with the degree of inflammation,allowing effective monitoring of the effects of fibreoptic BAL therapy and providing a reliable basis for the assessment of radiation-free dynamics at the bedside.
邢蕊;刘莹
唐山市妇幼保健院 儿内二,河北 063000唐山市妇幼保健院 儿内二,河北 063000
医药卫生
重症肺炎儿童肺脏超声纤维支气管镜肺泡灌洗
severe pneumoniachildrenlung ultrasoundfibreoptic bronchoscopyalveolar lavage
《影像科学与光化学》 2026 (2)
114-119,149,7
河北省医学科学研究课题计划项目(20221763).
评论